News

ImThera Medical, has received Ethics Committee clearance to begin human clinical trials in Belgium. The trials will include ImThera’s Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy to treat obstructive

InterMune has announced that its partner Roche has begun dosing in a phase 1b multiple ascending dose (MAD) study of ITMN-191 (RG7227) boosted by low-dose ritonavir in patients

MSD has presented a post-hoc analysis of data pooled from studies of 104 weeks in duration, which showed ‘Januvia’ (sitagliptin), when taken alone or in combination with metformin,

Cordis has announced that it has reached an agreement with Boston Scientific resolving its Palmaz infringement suit relating to Boston’s NIR stent. Cordis also settled several other cardiology-related

Dynavax Technologies has announced the initiation of a phase 3 registration trial for Heplisav hepatitis B vaccine in individuals with chronic kidney disease. A second registration trial, a

Scarab Genomics has introduced ScarabXpress, the latest strain in the multiple-deletion series (MDS) of its Clean Genome E coli. Based on the MDS42 strain, ScarabXpress T7lac contains a

Mankind has presented Afresa study data at the 45th Annual Meeting of the European Association for the Study of Diabetes. The data shows that Afresa Inhalation Powder is

Boston Scientific has announced the settlement of more than a dozen lawsuits involving Johnson & Johnson, including the Palmaz-NIR suit. The company said that all the disputes involved

SeraCare Life Sciences has announced that the company has been awarded two new contracts from the Centers for Disease Control (CDC) and the National Institutes of Health (NIH)